A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

Orange County is home to some of the hottest medical device and biotechnology companies, producing a range of drugs and ...

Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe ...

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

For young Indians grappling with aortic valve disease, the Ross procedure offers a lifeline—one that restores vitality ...

Transcatheter Aortic Valve Replacement Market outlook through 2035, highlighting key trends, growth drivers, challenges, and future opportunities ...

These findings suggest a more liberal approach to ascending aortic surgery in patients with BAV undergoing valve replacement, but improved risk stratification is needed. There is a significant growth ...

Aortic stenosis: With this condition, the aortic valve doesn’t open completely when it should, making the heart have to pump harder to get blood through the valve and into the aorta. It can lead to ...

CHICAGO, IL—Patients with asymptomatic severe aortic stenosis who are watched until symptoms develop before undergoing TAVI are a greater risk of dying, being hospitalized for heart failure (HF), or ...

The extent of cardiac damage has been shown to be associated with increased mortality, repeat hospitalization, and decreased quality of life after aortic valve replacement (AVR). However, the ...